logo
Plus   Neg
Share
Email

EVOTEC, Indivumed Reach First Milestone In Joint Collaboration

Evotec SE (EVTCY.PK,EVOTF.PK), a German drug discovery and development company, and Indivumed GmbH announced Monday the reaching of first milestone in their joint collaboration to identify new therapeutic targets for the treatment of colorectal cancer.

Under the collaboration deal terms, Evotec received full access to the colorectal cancer or CRC multi-omics data of IndivuType. The milestone of selecting three novel drug targets was achieved in less than three months.

IndivuType is a business unit of Indivumed that offers true multi-omics database for individualised cancer therapy.

The companies noted that the first set of identified targets will now be progressed towards first-in-class therapeutics for the treatment of CRC using Evotec's multimodality drug discovery and development platforms.

Four additional candidate targets identified by Indivumed's bioinformatic and analytics will also enter the joint development programme.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration has granted accelerated approval to Tazverik for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection. Epithelioid sarcoma is a rare sub-type of soft... STIHL recalls about 16,400 STIHL RE 90 pressure washers due to injury hazard. According to the company, the recalled pressure washer nozzle can disconnect from the spray wand when under pressure during use, posing an injury hazard. STIHL said it received seven reports of the nozzle detaching from... CVS Health Corp. launched 13 new HealthHUB locations in CVS Pharmacy stores across Philadelphia and South New Jersey. The healthcare company said it developed the HealthHUB store format to help people manage chronic conditions more conveniently and affordably. The store also features health and wellness products, clinical services and expertise.
Follow RTT
>